S3140 Gastric Polyps Prevalence, Characteristics, and Associated Factors in a Middle Eastern Population: Insights From a 5-Year Retrospective Analysis in a Tertiary Hospital

Introduction: Gastric polyps (GPs) are mucosal growths with unclear etiology, though Helicobacter pylori infection and proton pump inhibitor (PPI) use are known risk factors. Their prevalence ranges from 0.6% to 6%, varying by ethnicity, geography, and clinical setting. Often asymptomatic, GPs can present with anemia, bleeding, or epigastric pain. Hyperplastic and fundic gland polyps are the most common subtypes. Despite their clinical relevance, data from Middle Eastern populations remain limited. This study aims to assess the prevalence and potential risk factors of GPs in a Middle Eastern cohort. Methods: We conducted a retrospective analysis of patients who underwent esophagogastroduodenoscopy (EGD) for any indication at a tertiary hospital in the Middle East between 2017 and 2022. Institutional Review Board (IRB) approval was obtained. Two cohorts were identified: patients with GPs (cohort 1) and those without (cohort 2). Collected data included demographics, H. pylori status, PPI use, endoscopic findings, and histopathological results. Patients with missing data from EGD or clinical records were excluded. Statistical analysis was performed using Statistical Package for the Social Sciences. Results: GPs were identified in 312 (4.9%) out of 6,389 EGDs. Among patients with GPs, the mean age was 61.7 years, and 65.7% were women. Epigastric pain was the most frequently reported symptom (47.6%), while gastritis was the most common endoscopic finding (60.9%). PPI use was observed in 76% of patients with GPs compared to 31.48% in the comparison cohort. H. pylori was detected in 57.4% of patients with GPs versus 47.14% in the comparison cohort. Hyperplastic polyps (59.3%) and fundic gland polyps (36.5%) were the most common subtypes. Gastric polyps were associated with female sex (P < 0.001), older age (P < 0.001), and PPI use (P < 0.001). Subtype analysis showed fundic gland polyps were associated with female sex (P = 0.008) and PPI use (P = 0.011), while hyperplastic polyps were associated with PPI use (P < 0.001) and iron deficiency anemia (P = 0.011). Conclusion: In this study, gastric polyps were identified in 4.9% of patients, with hyperplastic and fundic gland polyps as the most common subtypes. PPI use was associated with GPs and their subtypes, while no association was found with H. pylori, in contrast to the existing literature. These findings contribute to understanding GP patterns and emphasize the need for further research on risk factors and management in Middle Eastern populations.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001140020.69775.cb
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3140 Gastric Polyps Prevalence, Characteristics, and Associated Factors in a Middle Eastern Population: Insights From a 5-Year Retrospective Analysis in a Tertiary Hospital

The American Journal of Gastroenterology
Esophageal Cancer Research and Treatment
article

S3140 Gastric Polyps Prevalence, Characteristics, and Associated Factors in a Middle Eastern Population: Insights From a 5-Year Retrospective Analysis in a Tertiary Hospital

article en

Abstract

Introduction: Gastric polyps (GPs) are mucosal growths with unclear etiology, though Helicobacter pylori infection and proton pump inhibitor (PPI) use are known risk factors. Their prevalence ranges from 0.6% to 6%, varying by ethnicity, geography, and clinical setting. Often asymptomatic, GPs can present with anemia, bleeding, or epigastric pain. Hyperplastic and fundic gland polyps are the most common subtypes. Despite their clinical relevance, data from Middle Eastern populations remain limited. This study aims to assess the prevalence and potential risk factors of GPs in a Middle Eastern cohort. Methods: We conducted a retrospective analysis of patients who underwent esophagogastroduodenoscopy (EGD) for any indication at a tertiary hospital in the Middle East between 2017 and 2022. Institutional Review Board (IRB) approval was obtained. Two cohorts were identified: patients with GPs (cohort 1) and those without (cohort 2). Collected data included demographics, H. pylori status, PPI use, endoscopic findings, and histopathological results. Patients with missing data from EGD or clinical records were excluded. Statistical analysis was performed using Statistical Package for the Social Sciences. Results: GPs were identified in 312 (4.9%) out of 6,389 EGDs. Among patients with GPs, the mean age was 61.7 years, and 65.7% were women. Epigastric pain was the most frequently reported symptom (47.6%), while gastritis was the most common endoscopic finding (60.9%). PPI use was observed in 76% of patients with GPs compared to 31.48% in the comparison cohort. H. pylori was detected in 57.4% of patients with GPs versus 47.14% in the comparison cohort. Hyperplastic polyps (59.3%) and fundic gland polyps (36.5%) were the most common subtypes. Gastric polyps were associated with female sex (P < 0.001), older age (P < 0.001), and PPI use (P < 0.001). Subtype analysis showed fundic gland polyps were associated with female sex (P = 0.008) and PPI use (P = 0.011), while hyperplastic polyps were associated with PPI use (P < 0.001) and iron deficiency anemia (P = 0.011). Conclusion: In this study, gastric polyps were identified in 4.9% of patients, with hyperplastic and fundic gland polyps as the most common subtypes. PPI use was associated with GPs and their subtypes, while no association was found with H. pylori, in contrast to the existing literature. These findings contribute to understanding GP patterns and emphasize the need for further research on risk factors and management in Middle Eastern populations.

The American Journal of GastroenterologyVol. 120(10S2)
Good health and well-being
Openalex Percentile: Top 29%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.